According to ProQR's latest financial reports the company has a price-to-book ratio of 3.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.51 | -5.12% |
2022-12-31 | 3.70 | -19.62% |
2021-12-31 | 4.60 | 51.87% |
2020-12-31 | 3.03 | -35.36% |
2019-12-31 | 4.69 | -18.93% |
2018-12-31 | 5.79 | 165.81% |
2017-12-31 | 2.18 | 6.42% |
2016-12-31 | 2.05 | -0.91% |
2015-12-31 | 2.06 | -45.7% |
2014-12-31 | 3.80 | |
2013-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Atara Biotherapeutics ATRA | -0.8300 | -124.06% | ๐บ๐ธ USA |
Agenus
AGEN | -1.71 | -149.60% | ๐บ๐ธ USA |
Actinium Pharmaceuticals ATNM | 6.30 | 82.78% | ๐บ๐ธ USA |